Publication & Citation Trends
Publications
0 total
Abstract 4364195: A transformative LDL cholesterol–lowering in vivo CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primates
Cited by 1
Semantic Scholar
Pharmacokinetics, Biodistribution and Anti-CD19 CAR Expression Kinetics in Vitro and after In Vivo Delivery of a CD8-Targeted Fusosome in NSG Mice OA
Cited by 0
Semantic Scholar
In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques (M. nemestrina) Results in B Cell Depletion OA
Cited by 4
Semantic Scholar
Abstract LB105: In vivo CAR T therapy: targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication
Cited by 1
Semantic Scholar
A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes. OA
Cited by 82
Semantic Scholar
Expression of Concern. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515 OA
Cited by 0
Semantic Scholar
Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function OA
Cited by 52
Semantic Scholar
Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance OA
Cited by 44
Semantic Scholar
Research Topics
Pancreatic function and diabetes
(10)
Adipose Tissue and Metabolism
(6)
Metabolism, Diabetes, and Cancer
(5)
Muscle Physiology and Disorders
(3)
Pluripotent Stem Cells Research
(3)
Affiliations
Brigham and Women's Hospital
Merck & Co., Inc., Rahway, NJ, USA (United States)
Joslin Diabetes Center
Harvard University
Sana Biotechnology (United States)